COVID-19 Therapeutics: What Do the Guidelines Say?
ABOUT THIS EPISODE
Originally aired: March 11, 2021
Several prominent COVID-19 guideline panels have updated their recommendations for the use of tocilizumab, remdesivir, monoclonal antibodies, and other therapeutics in patients with COVID-19. This episode highlights key takeaways from the National Institutes of Health, European Respiratory Society, Infectious Diseases Society of America, and Surviving Sepsis Campaign COVID-19 guidelines.
Moderator
Casey Cable, MD, MSc
Panelists
Barbara Jones, MD, MSc
Stefano Aliberti, MD